Erratum to: Analysis of peri-islet CD45-positive leucocytic infiltrates in long-standing type 1 diabetic patients [Diabetologia DOI 10.1007/s00125-015-3519-6];Analysis of peri-islet CD45-positive leucocytic infiltrates in long-standing type 1 diabetic patients

Diabetologia

Volumn 58, Issue 5, 2015, Pages 1024-1035

  Reddy, Shiva ^a   Zeng, Nina ^a   Al Diery, Hussam ^a   Jung, Doran ^a   Yeu, Clifton ^a   Joret, Maximilian O ^a   Merrilees, Mervyn J ^a   Wu, Fiona ^b  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b AUCKLAND DISTRICT HEALTH BOARD   (New Zealand)

Author keywords

Beta cells; Human type 1 diabetes; Insulitis; Islets; Leucocytes

Indexed keywords

CD45 ANTIGEN;

ADOLESCENT; ADULT; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LEUKOCYTE; MALE; METABOLISM; PANCREAS ISLET; PRESCHOOL CHILD; YOUNG ADULT;

ADOLESCENT; ADULT; ANTIGENS, CD45; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; ISLETS OF LANGERHANS; LEUKOCYTES; MALE; YOUNG ADULT;

EID: 84939974788     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-015-3631-7     Document Type: Erratum

References (41)

1. Eisenbarth GS (1986) Type 1 diabetes mellitus. A chronic autoimmune disease. N Engl J Med 314:1360–1368
2. von Herrath M, Sanda S, Herold K (2007) Type 1 diabetes as a relapsing-remitting disease? Nat Rev Immunol 7:988–994
3. Mathis D, Vence L, Benoist C (2001) β-Cell death during progression to diabetes. Nature 414:792–798
4. Calderon B, Carrero JA, Miller MJ, Unanue ER (2011) Cellular and molecular events in the localization of diabetogenic T cells to islets of Langerhans. Proc Natl Acad Sci U S A 108:1561–1566
5. Coppieters KT, Dotta F, Amirian N et al (2012) Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patients. J Exp Med 209:51–60
6. Skowera A, Ellis RJ, Varela-Calviño R et al (2008) CTLs are targeted to kill β cells in patients with type 1 diabetes through recognition of a glucose-regulated preproinsulin epitope. J Clin Invest 118:3390–3402
7. Eizirik DL, Colli ML, Ortis F (2009) The role of inflammation in insulitis and β-cell loss in type 1 diabetes. Nat Rev Endocrinol 5:219–226
8. Pirot P, Cardozo AK, Eizirik DL (2008) Mediators and mechanisms of pancreatic beta-cell death in type 1 diabetes. Arq Bras Endocrinol Metabol 52:156–165
9. Faideau B, Larger E, Lepault F, Carel JC, Boitard C (2005) Role of β-cells in type 1 diabetes pathogenesis. Diabetes 54(Suppl 2):S87–S96
10. Roep BO, Atkinson M, von Herrath M (2004) Satisfaction (not) guaranteed: re-evaluating the use of animal models of type 1 diabetes. Nat Rev Immunol 4:989–997
11. Atkinson MA, Gianani R (2009) The pancreas in human type 1 diabetes: providing new answers to age-old questions. Curr Opin Endocrinol Diabetes Obes 16:279–285
12. Bottazzo GF, Dean BM, McNally JM, MacKay EH, Swift PG, Gamble DR (1985) In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis. N Engl J Med 313:353–360
13. Gianani R, Campbell-Thompson M, Sarkar SA et al (2010) Dimorphic histopathology of long-standing childhood-onset diabetes. Diabetologia 53:690–698
14. Reddy S, Wu D, Swinney C, Elliott RB (1995) Immunohistochemical analyses of pancreatic macrophages and CD4 and CD8 T cell subsets prior to and following diabetes in the NOD mouse. Pancreas 11:16–25
15. Gepts W (1965) Pathologic anatomy of the pancreas in juvenile diabetes mellitus. Diabetes 14:619–633
16. Foulis AK, Liddle CN, Farquharson MA, Richmond JA, Weir RS (1986) The histopathology of the pancreas in type 1 (insulin-dependent) diabetes mellitus: a 25-year review of deaths in patients under 20 years of age in the United Kingdom. Diabetologia 29:267–274
17. Richardson SJ, Willcox A, Bone AJ, Morgan NG, Foulis AK (2011) Immunopathology of the human pancreas in type-1 diabetes. Semin Immunopathol 33:9–21
18. Willcox A, Richardson SJ, Bone AJ, Foulis AK, Morgan NG (2008) Analysis of islet inflammation in human type 1 diabetes. Clin Exp Immunol 155:173–181
19. Coppieters KT, von Herrath MG (2009) Histopathology of type 1 diabetes: old paradigms and new insights. Rev Diabet Stud 6:85–96
20. In’t Veld P (2011) Insulitis in human type 1 diabetes: the quest for an elusive lesion. Islets 3:131–138
21. Keenan HA, Sun JK, Levine J et al (2010) Residual insulin production and pancreatic β-cell turnover after 50 years of diabetes: Joslin Medalist Study. Diabetes 59:2846–2853
22. Meier JJ, Bhushan A, Butler AE, Rizza RA, Butler PC (2005) Sustained beta cell apoptosis in patients with long-standing type 1 diabetes: indirect evidence for islet regeneration? Diabetologia 48:2221–2228
23. Eizirik DL, Sandler S, Welsh N et al (1994) Cytokines suppress human islet function irrespective of their effects on nitric oxide generation. J Clin Invest 93:1968–1974
24. Eizirik DL, Mandrup-Poulsen T (2001) A choice of death—the signal-transduction pathway of immune-mediated beta-cell apoptosis. Diabetologia 44:2115–2133
25. Cardozo AK, Ortis F, Storling J et al (2005) Cytokines downregulate the sarcoendoplasmic reticulum pump Ca2+ ATPase 2b and deplete endoplasmic reticulum Ca2+, leading to induction of endoplasmic reticulum stress in pancreatic β-cells. Diabetes 54:452–461
26. Marhfour I, Lopez XM, Lefkaditis D et al (2012) Expression of endoplasmic reticulum stress markers in the islets of patients with type 1 diabetes. Diabetologia 55:2417–2420
27. Tersey SA, Nishiki Y, Templin AT et al (2012) Islet β-cell endoplasmic reticulum stress precedes the onset of type 1 diabetes in the nonobese diabetic mouse model. Diabetes 61:818–827
28. Pugliese A, Yang M, Kusmarteva I et al (2014) The Juvenile Diabetes Research Foundation Network for Pancreatic Organ Donors with Diabetes (nPOD) Program: goals, operational model and emerging findings. Pediatr Diabetes 15:1–9
29. Campbell-Thompson ML, Atkinson MA, Butler AE et al (2013) The diagnosis of insulitis in human type 1 diabetes. Diabetologia 56:2541–2543
30. Oldstone MB, Edelmann KH, McGavern DB, Cruite JT, Welch MJ (2012) Molecular anatomy and number of antigen specific CD8 T cells required to cause type 1 diabetes. PLoS Pathog 8:e1003044
31. Korpos É, Kadri N, Kappelhoff R et al (2013) The peri-islet basement membrane, a barrier to infiltrating leukocytes in type 1 diabetes in mouse and human. Diabetes 62:531–542
32. Lakey JRT, Suarez-Pinzon WL, Strynadka K et al (2001) Peroxynitrite is a mediator of cytokine-induced destruction of human pancreatic islet β cells. Lab Invest 81:1683–1692
33. Yang C, diIorio P, Jurczyk A, O’Sullivan-Murphy B, Urano F, Bortell R (2013) Pathological endoplasmic reticulum stress mediated by the IRE1 pathway contributes to pre-insulitic beta cell apoptosis in a virus-induced rat model of type 1 diabetes. Diabetologia 56:2638–2646
34. Oram RA, Jones AG, Besser REJ et al (2014) The majority of patients with long-duration type 1 diabetes are insulin microsecretors and have functioning beta cells. Diabetologia 57:187–191
35. Butler AE, Galasso R, Meier JJ, Basu R, Rizza RA, Butler PC (2007) Modestly increased beta cell apoptosis but no increased beta cell replication in recent-onset type 1 diabetic patients who died of diabetic ketoacidosis. Diabetologia 50:2323–2331
36. Coppieters KT, Wiberg A, Amirian N, Kay TW, von Herrath MG (2011) Persistent glucose transporter expression on pancreatic beta cells from longstanding type 1 diabetic individuals. Diabetes Metab Res Rev 27:746–754
37. Reddy S, Young M, Poole CA, Ross JM (1998) Loss of glucose transporter-2 precedes insulin loss in the nonobese diabetic and the low-dose streptozotocin mouse models: a comparative immunohistochemical study by light and confocal microscopy. Gen Comp Endocrinol 111:9–19
38. Spencer J, Peakman M (2008) Post-mortem analysis of islet pathology in type 1 diabetes illuminates the life and death of the β cell. Clin Exp Immunol 155:125–127
39. Campbell-Thompson M, Wasserfall C, Montgomery EL, Atkinson MA, Kaddis JS (2012) Pancreas organ weight in individuals with disease-associated autoantibodies at risk for developing type 1 diabetes. JAMA 308:2337–2339
40. Creutzfeldt W, Gleichmann D, Otto J, Stöckmann F, Maisonneuve P, Lankisch PG (2005) Follow-up of exocrine pancreatic function in type-1 diabetes mellitus. Digestion 72:71–75
41. Rodriguez-Calvo T, Ekwall O, Amiran N, Zapardiel-Gonzalo J, von Herrath MG (2014) Increased immune cell infiltration of the exocrine pancreas: a possible contribution to the pathogenesis of type 1 diabetes. Diabetes 63:3880–3890